# Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases

> **NCT07145736** · PHASE4 · RECRUITING · sponsor: **Kirby Institute** · enrollment: 52000 (estimated)

## Conditions studied

- Onchocerciasis
- Ascaris Lumbricoides Infection
- Trichuris Trichiura; Infection
- Hookworm Infections
- Scabies

## Interventions

- **DRUG:** Moxidectin
- **DRUG:** Ivermectin

## Key facts

- **NCT ID:** NCT07145736
- **Lead sponsor:** Kirby Institute
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-08-04
- **Primary completion:** 2029-03-31
- **Final completion:** 2029-06-30
- **Target enrollment:** 52000 (ESTIMATED)
- **Last updated:** 2025-11-21

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07145736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07145736, "Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07145736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*